- Home
- STM vs NTRA Comparison
STM vs NTRA Comparison
Compare STM & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STM
- NTRA
- Stock Information
- Founded
- STM 1987
- NTRA 2003
- Country
- STM Netherlands
- NTRA United States
- Employees
- STM N/A
- NTRA N/A
- Industry
- STM Semiconductors
- NTRA Medical Specialities
- Sector
- STM Technology
- NTRA Health Care
- Exchange
- STM Nasdaq
- NTRA Nasdaq
- Market Cap
- STM 23.4B
- NTRA 22.1B
- IPO Year
- STM 1994
- NTRA 2015
- Fundamental
- Price
- STM $25.75
- NTRA $167.46
- Analyst Decision
- STM Buy
- NTRA Strong Buy
- Analyst Count
- STM 8
- NTRA 16
- Target Price
- STM $37.63
- NTRA $160.63
- AVG Volume (30 Days)
- STM 5.5M
- NTRA 1.2M
- Earning Date
- STM 01-30-2025
- NTRA 02-26-2025
- Dividend Yield
- STM 1.40%
- NTRA N/A
- EPS Growth
- STM N/A
- NTRA N/A
- EPS
- STM 2.27
- NTRA N/A
- Revenue
- STM $14,229,000,000.00
- NTRA $1,531,955,000.00
- Revenue This Year
- STM N/A
- NTRA $54.35
- Revenue Next Year
- STM N/A
- NTRA $10.17
- P/E Ratio
- STM $11.15
- NTRA N/A
- Revenue Growth
- STM N/A
- NTRA 54.94
- 52 Week Low
- STM $23.66
- NTRA $62.96
- 52 Week High
- STM $49.05
- NTRA $183.00
- Technical
- Relative Strength Index (RSI)
- STM 54.12
- NTRA 52.44
- Support Level
- STM $24.60
- NTRA $163.42
- Resistance Level
- STM $26.90
- NTRA $174.15
- Average True Range (ATR)
- STM 0.54
- NTRA 8.16
- MACD
- STM 0.08
- NTRA -0.75
- Stochastic Oscillator
- STM 64.51
- NTRA 44.26
About STM STMicroelectronics N.V.
A merger between Italian firm SGS Microelettronica and the nonmilitary business of Thomson Semiconducteurs in France formed STMicroelectronics in 1987. STMicroelectronics is a leader in a variety of semiconductor products, including analog chips, discrete power semiconductors, microcontrollers, and sensors. It is an especially prominent chip supplier to the industrial and automotive industries.
About NTRA Natera Inc.
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.